Alle verbonden artikelen

p53 Reactivation by PRIMA-1 Met (APR-246) sensitises V600E/K BRAF melanoma to vemurafenib.

Auteurs : Krayem M, Journe F, Wiedig M, Morandini R, Najem A, Sales F, Van Kempen LC, Sibille C, Awada A, Marine JC, Ghanem G
Jaar : 2016
Journal : Eur J Cancer
Volume : 55
Pagina's : 98-110

Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials.

Auteurs : Ghislain I, Zikos E, Coens C, Quinten C, Balta V, Tryfonidis K, Piccart-Gebhart M, Zardavas D, Nagele E, Bjelic-Radisic V, Cardoso F, Sprangers MA, Velikova G, Bottomley A
Jaar : 2016
Journal : Lancet Oncol
Volume : 17
Pagina's : e294-304

Corrigendum to Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicenter prospective study" [J. Geriatr. Oncol. 6 (2015) 401-410]."

Auteurs : Baitar A, Kenis C, Moor R, Decoster L, Luce S, Bron D, Van Rijswijk R, Rasschaert M, Langenaeken C, Jerusalem G, Lobelle JP, Flamaing J, Milisen K, Wildiers H
Jaar : 2016
Journal : J Geriatr Oncol
Volume : 7
Pagina's : 142-143

Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.

Auteurs : Bottomley A, Pe M, Sloan J, Basch E, Bonnetain F, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Dueck AC, Devlin N, Flechtner HH, Gotay C, Greimel E, Griebsch I, Groenvold M, Hamel JF, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Moinpour CM, Musoro J, OConnor D, Oliver K, Piault-Louis E, Piccart-Gebhart M, Pimentel FL, Quinten C, Reijneveld JC, Schürmann C, Smith AW, Soltys KM, Taphoorn MJ, Velikova G, Coens C
Jaar : 2016
Journal : Lancet Oncol
Volume : 17
Pagina's : e510-e514

Emerging Drugs Targeting Human Epidermal Growth Factor Receptor 2 (Her2) In The Treatment Of Breast Cancer.

Auteurs : Awada G, Gombos A, Aftimos P, Awada A
Jaar : 2016
Journal : Expert Opin Emerg Drugs
Volume : 21(1)
Pagina's : 91-101

Bisphosphonate-related osteonecrosis of the jaw: a review of the potential efficacy of low-level laser therapy.

Auteurs : Latifyan S, Genot MT, Klastersky J
Jaar : 2016
Journal : Support Care Cancer
Volume : 24(9)
Pagina's : 3687-93

Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From BOLERO-2.

Auteurs : Hortobagyi GN, Chen D, Piccart-Gebhart M, Rugo HS, Burris HA 3rd, Pritchard KI, Campone M, Noguchi S, Perez AT, Deleu I, Shtivelband M, Masuda N, Dakhil S, Anderson I, Robinson DM, He W, Garg A, McDonald ER 3rd, Bitter H, Huang A, Taran T, Bachelot T, Lebrun F, Lebwohl D, Baselga J
Jaar : 2016
Journal : J Clin Oncol
Volume : 34(5)
Pagina's : 419-26

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.

Auteurs : Lambertini M, Pinto AC, Ameye L, Jongen L, Del Mastro L, Puglisi F, Poggio F, Bonotto M, Floris G, Van Asten K, Wildiers H, Neven P, de Azambuja E, Paesmans M, Azim HA Jr
Jaar : 2016
Journal : Br J Cancer
Volume : 115(12)
Pagina's : 1471-78

Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells.

Auteurs : Mittal D, Caramia F, Michiels S, Joensuu H, Kellokumpu-Lehtinen PL, Sotiriou C, Loi S, Smyth MJ
Jaar : 2016
Journal : Cancer Res
Volume : 76
Pagina's : 264-74

Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma: A Feasibility Study.

Auteurs : Dhondt V, Goffin F, Roca L, Dresse D, Leroy C, Kerger J, Cordier L, de Forges H, Veys I, Liberale G
Jaar : 2016
Journal : Int J Gynecol Cancer
Volume : 26(5)
Pagina's : 912-7

Targeted adjuvant therapy in breast cancer.

Auteurs : Zardavas D, Tryfonidis K, Goulioti T, Piccart-Gebhart M
Jaar : 2016
Journal : Expert Rev Anticancer Ther
Volume : 16(12)
Pagina's : 1263-75

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer.

Auteurs : Elez E, Hendlisz A, Delaunoit T, Sastre J, Cervantes A, Varea R, Chao G, Wallin J, Tabernero J
Jaar : 2016
Journal : Br J Cancer
Volume : 114(4)
Pagina's : 372-80

Learning from the tsunami" of immune checkpoint inhibitors in 2015."

Auteurs : Kourie HR, Awada G, Awada A
Jaar : 2016
Journal : Crit Rev Oncol Hematol
Volume : 101
Pagina's : 213-220

Salvage esophagectomy after failure of definitive radiochemotherapy for esophageal cancer.

Auteurs : Farinella E, Safar A, Nasser HA, Bouazza F, Liberale G, Paesmans M, Marechal R, Van Laethem JL, Hendlisz A, VanHoutte P, El Nakadi I
Jaar : 2016
Journal : J Surg Oncol
Volume : 114
Pagina's : 833-837

Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients.

Auteurs : Sideris S, Aoun F, Martinez Chanza N, Latifyan S, Awada A, Costante G, Gil T
Jaar : 2016
Journal : J Endocrinol Invest
Volume : 39(7)
Pagina's : 729-38

Fever of unknown origin in cancer patients.

Auteurs : Loizidou A, Aoun M, Klastersky J
Jaar : 2016
Journal : Crit Rev Oncol Hematol
Volume : 101
Pagina's : 125-30

Paget bone disease demonstrated on 68Ga-PSMA ligand PET/CT.

Auteurs : Artigas C, Alexiou J, Garcia C, Wimana Z, Otte FX, Gil T, Van Velthoven R, Flamen P
Jaar : 2016
Journal : Eur J Nucl Med Mol Imaging
Volume : 43(1)
Pagina's : 195-6

Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.

Auteurs : Bense RD, Sotiriou C, Piccart-Gebhart M, Haanen JB, van Vugt MA, de Vries EG, Schröder CP, Fehrmann RS
Jaar : 2016
Journal : J Natl Cancer Inst
Volume : 109

Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial.

Auteurs : Ignatiadis M, Rack B, Rothé F, Riethdorf S, Decraene C, Bonnefoi H, Dittrich C, Messina C, Beauvois M, Trapp E, Goulioti T, Tryfonidis K, Pantel K, Repollet M, Janni W, Piccart-Gebhart M, Sotiriou C, Litiere S, Pierga JY
Jaar : 2016
Journal : Eur J Cancer
Volume : 63
Pagina's : 97-104

Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea: proof of concept.

Auteurs : VAN DEN Heuvel B, Peeters M, Hendlisz A, Van den Eynde M, Machiels G, Dero I, Geboes K, De Man M, Hendrickx K, Delaunoit T, Monsaert E, Vanderstraten E, Van Laethem JL, Lybaert W, Holbrechts S, Rolfo C
Jaar : 2016
Journal : Minerva Chir